Home › Funds › Ikarian Capital, LLC › BHVN
Ikarian Capital, LLC position in BHVN
BIOHAVEN LTD · Health Care
Ikarian Capital, LLC reported holding 748,181 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 1.79% of its reported portfolio and ranking #14 among its reported holdings. Ikarian Capital, LLC has disclosed BHVN holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's BHVN position evolved
Ikarian Capital, LLC first disclosed a stake in BHVN in Q3 2023 at 106,138 shares (US$2.8M). The position peaked in Q3 2024 at 325,600 shares, worth US$16.3M. Across 9 filings, Ikarian Capital, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 748,181 shares valued at US$11.1M — an increase of 335,700 shares quarter over quarter.. Notable position changes include a 165% increase in Q3 2025 (shares fell 25% over the following quarter), a 94% increase in Q1 2026 (shares rose 76% over the following quarter), a 81% increase in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 106.14K | $2.76M | New |
| Q1 2024 | 223.70K | $12.23M | New |
| Q3 2024 | 325.60K | $16.27M | New |
| Q1 2025 | 348.20K | $8.37M | New |
| Q2 2025 | 300.00K | $4.23M | Reduce |
| Q3 2025 | 796.40K | $11.95M | Add |
| Q4 2025 | 212.48K | $2.40M | Reduce |
| Q1 2026 | 412.48K | $3.49M | Add |
| Q2 2026 | 748.18K | $11.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held BHVN?
Ikarian Capital, LLC has disclosed BHVN holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
What is Ikarian Capital, LLC's current position in BHVN?
As of Q2 2026, Ikarian Capital, LLC holds 748.18K shares of BHVN (BIOHAVEN LTD), valued at $11.13M, representing 1.79% of its reported portfolio and ranking #14.
Has Ikarian Capital, LLC been buying or selling BHVN?
In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in BHVN. The position peaked in Q3 2024 at 325.60K shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.